Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma.
about
Emerging targeted therapies for melanoma treatment (review)Cystine-knot peptides targeting cancer-relevant human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials.Precision Medicine and PET/Computed Tomography in Melanoma.Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.Ipilimumab for the treatment of melanoma
P2860
Q26829997-59A3B2F0-88B3-49E5-9691-1EB4DE6759EDQ35627631-BA529B34-78FE-4974-8D6F-DED52BB3389EQ38549236-4DFA5638-C174-4CEC-82AE-CA9CC9B051D7Q42925679-2089E557-7FD9-442F-AABB-87B956AEED8FQ47722682-A8DA4F01-A6D5-4E90-8DCC-F00E5475973FQ51313427-5B6C6241-20E5-4E73-88AD-99B13DCDC442Q56896291-B145CEC4-63FD-4880-8C3D-D290FF1EC0CF
P2860
Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma.
@en
type
label
Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma.
@en
prefLabel
Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma.
@en
P2860
P356
P1476
Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma.
@en
P2860
P304
P356
10.1155/2013/423829
P577
2013-04-21T00:00:00Z